Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia.

Rishi, Pukhraj; Rishi, Ekta; Venkataraman, Anusha; Gopal, Lingam; Sharma, Tarun; Bhende, Muna; Ratra, Dhanashree; Sen, Pratik Ranjan; Sen, Parveen

Rishi, Pukhraj; Rishi, Ekta; Venkataraman, Anusha; Gopal, Lingam; Sharma, Tarun; Bhende, Muna; Ratra, Dhanashree; Sen, Pratik Ranjan; Sen, Parveen.

Indian J Ophthalmol ; 2011 May; 59(3): 242-246

Article in En | IMSEAR | ID: sea-136183

Subject(s)

Angiogenesis Inhibitors/administration & dosage; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization/drug therapy; Choroidal Neovascularization/etiology; Drug Therapy, Combination; Humans; Intravitreal Injections; Myopia, Degenerative/complications; Photochemotherapy; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide/administration & dosage

Key words

Bevacizumab; choroidal neovascularization; intravitreal injection; myopia; photodynamic therapy; ranibizumab; triamcinolone acetonide; vascular endothelial growth factor

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Photochemotherapy / Humans / Triamcinolone Acetonide / Retrospective Studies / Treatment Outcome / Choroidal Neovascularization / Angiogenesis Inhibitors / Myopia, Degenerative / Drug Therapy, Combination / Intravitreal Injections Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Indian J Ophthalmol Year: 2011 Type: Article

Fulltext

Add to My VHL

XML

Search on Google